NO20004225L - Fremgangsmate for fremstilling av belagte, kuleformige granulatkorn - Google Patents

Fremgangsmate for fremstilling av belagte, kuleformige granulatkorn

Info

Publication number
NO20004225L
NO20004225L NO20004225A NO20004225A NO20004225L NO 20004225 L NO20004225 L NO 20004225L NO 20004225 A NO20004225 A NO 20004225A NO 20004225 A NO20004225 A NO 20004225A NO 20004225 L NO20004225 L NO 20004225L
Authority
NO
Norway
Prior art keywords
grains
spherical granular
encased
polymer dispersion
prostane
Prior art date
Application number
NO20004225A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004225D0 (no
Inventor
Torsten Wagner
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20004225D0 publication Critical patent/NO20004225D0/no
Publication of NO20004225L publication Critical patent/NO20004225L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Steroid Compounds (AREA)
NO20004225A 1998-02-24 2000-08-23 Fremgangsmate for fremstilling av belagte, kuleformige granulatkorn NO20004225L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19808634A DE19808634A1 (de) 1998-02-24 1998-02-24 Mantel für eine pharmazeutische Zusammensetzung
PCT/EP1999/001100 WO1999043303A1 (de) 1998-02-24 1999-02-24 Verfahren zur herstellung von ummantelten, sphärischen granulatkörnern

Publications (2)

Publication Number Publication Date
NO20004225D0 NO20004225D0 (no) 2000-08-23
NO20004225L true NO20004225L (no) 2000-09-28

Family

ID=7859315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004225A NO20004225L (no) 1998-02-24 2000-08-23 Fremgangsmate for fremstilling av belagte, kuleformige granulatkorn

Country Status (18)

Country Link
US (1) US6723372B1 (cs)
EP (1) EP1058542B1 (cs)
JP (1) JP2002504506A (cs)
KR (1) KR100623542B1 (cs)
AT (1) ATE303133T1 (cs)
AU (1) AU753261B2 (cs)
CA (1) CA2321969C (cs)
CZ (1) CZ299252B6 (cs)
DE (2) DE19808634A1 (cs)
DK (1) DK1058542T3 (cs)
ES (1) ES2247786T3 (cs)
HU (1) HU226066B1 (cs)
IL (1) IL137965A (cs)
NO (1) NO20004225L (cs)
PL (1) PL193071B1 (cs)
RU (1) RU2209060C2 (cs)
SK (1) SK284062B6 (cs)
WO (1) WO1999043303A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19828881A1 (de) * 1998-06-22 1999-12-23 Schering Ag Oxidationsinhibitor bei Prostan-Derivaten
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
DE60308828T2 (de) * 2003-05-20 2007-05-24 Ethypharm Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung
US8318230B2 (en) * 2005-05-02 2012-11-27 Henkel Ag & Co. Kgaa Use of debranched starch in extrusion-spheronization pharmaceutical pellets
US8022075B2 (en) 2005-11-30 2011-09-20 Fujifilm Ri Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
RU2702690C2 (ru) * 2015-08-13 2019-10-09 БИОЛИНГУС АйПи ЛЛСи Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые
CN106822013B (zh) * 2015-11-30 2020-05-12 北京泰德制药股份有限公司 前列环素类似物缓释制剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA935093A (en) 1969-07-28 1973-10-09 Eurand S.R.L. Method of preparing granules with controlled release of the active substance contained therein
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3622487A1 (de) * 1986-07-02 1988-01-14 Schering Ag Arzneimittel mit verzoegerter wirkstoffabgabe
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
JP3277342B2 (ja) * 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
DE4236025A1 (de) * 1992-10-24 1994-04-28 Merck Patent Gmbh Orale Arzneiformen
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
RU2117475C1 (ru) * 1995-11-02 1998-08-20 Химико-фармацевтическое акционерное общество открытого типа "Октябрь" Водная акриловая дисперсия для производства энтеральных лекарственных форм
JPH10139659A (ja) 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤

Also Published As

Publication number Publication date
RU2209060C2 (ru) 2003-07-27
SK284062B6 (sk) 2004-09-08
CA2321969A1 (en) 1999-09-02
DE19808634A1 (de) 1999-08-26
IL137965A (en) 2005-11-20
ES2247786T3 (es) 2006-03-01
SK12422000A3 (sk) 2001-04-09
KR20010041210A (ko) 2001-05-15
CZ20003088A3 (cs) 2000-11-15
JP2002504506A (ja) 2002-02-12
HUP0100752A2 (hu) 2001-08-28
EP1058542B1 (de) 2005-08-31
AU2835299A (en) 1999-09-15
CZ299252B6 (cs) 2008-05-28
WO1999043303A1 (de) 1999-09-02
PL193071B1 (pl) 2007-01-31
US6723372B1 (en) 2004-04-20
KR100623542B1 (ko) 2006-09-13
EP1058542A1 (de) 2000-12-13
ATE303133T1 (de) 2005-09-15
IL137965A0 (en) 2001-10-31
DE59912501D1 (de) 2005-10-06
PL342315A1 (en) 2001-06-04
DK1058542T3 (da) 2006-01-02
NO20004225D0 (no) 2000-08-23
HU226066B1 (en) 2008-04-28
CA2321969C (en) 2007-04-10
AU753261B2 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
US5595762A (en) Stabilized pulverulent active agents, compositions containing them, process for obtaining them and their applications
DE69525148T2 (de) Pharmazeutische formulierung
EP0761213A3 (en) Method of production of sustained-release preparation
CA2281420A1 (en) Preparation of pharmaceutically-active granules
CA2514446A1 (en) Composition comprising a mixture of active principles, and method of preparation
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
DE69434258D1 (de) Mikroverkapselte 1,2-benzazole
WO2002101412A3 (en) Spray freeze-dried compositions
DE59206345D1 (de) Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
WO1997006787A3 (en) Controlled release products
NO20001670L (no) Fremgangsmate for fremstilling av en smaksmaskert farmasoytisk blanding og smaksmaskert farmasoytisk blanding fremstilt ifolge denne fremgangsmaten, samt smaksmaskerte tyggbare tabletter
AU2001277570A1 (en) Oral pharmaceutical composition with controlled release and prolonged absorption
NO20004225L (no) Fremgangsmate for fremstilling av belagte, kuleformige granulatkorn
ATE94410T1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
DE3880919D1 (de) Stabilisierter futtermittelzusatz und verfahren zu seiner herstellung.
DE69929439D1 (de) Polyakrylsäure-granulate mit gesteuerter freigabe und verfahren zu dessen herstellung
CA2194610A1 (en) Sustained-Release Formulation of Animal Growth Hormone and Process for Preparation Thereof
IT1281876B1 (it) Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci.
JO2325B1 (en) A pharmaceutical composition with a flavoring taste and a process to prepare it
CA2334385A1 (en) Method of controlling release of n-substituted derivatives of aspartame in chewing gum and gum produced thereby
EP2358361B1 (en) Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
EP0735049A3 (en) Humectant, antistatic agent, dispersant and film-forming agent with polysaccharide as an effective principle; Process for the production of polysaccharides and Klebsiella strain
CA2306508A1 (en) Production of a directly compressible tabletting aid
DE60233685D1 (de) Verfahren zur herstellung einer zusammensetzung mis resultierende produkt
AU1868592A (en) New pyrethrinoid esters of 4-amino-2,3,5,6-tetrafluorophenyl methyl alcohol, their preparation process and their use as pesticides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application